Medtronic

Health Care Health Care Equipment Dublin, Ireland Last filing Jun 18, 2026 · FY2026

                    Revenue
                    FY2026
                
$36.4B
                    3y CAGR +5.2%
                    
                    P20
                    
                    n/a
                    
                    Net income
                    FY2026
                
$4.8B
                    Net margin +13.2%
                    
                    P80
                    
                    n/a
                    
                    Total assets
                    FY2026
                
$93.0B
                    ROA +5.2%
                    
                    P40
                    
                    n/a
                    
                    Operating cash flow
                    FY2026
                
$7.3B
                    FCF margin +14.9%
                    
                    P60
                    
                    n/a

14 yrs · FY2013–FY2026 9 filed · 0 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

27 accounts · 1 year

Total assets $93.0B

Total liabilities $43.0B

Shareholders equity $49.5B

Account	2026	Trend
Assets
Cash and Cash Equivalents	5.4%
Short Term Investments	20.0%
Accounts Receivable	18.3%
Inventory	16.4%
Other Current Assets	8.2%
Total Current Assets	68.2%
Property,Plant and Equipment	20.4%
Goodwill	117.1%
Intangible Assets	27.9%
Deferred Tax Assets	10.8%
Other Noncurrent Assets	11.4%
Total Assets	255.8%
Liabilities
Accounts Payable	7.3%
Accrued Liabilities	19.9%
Current Portion of Long Term Debt	4.9%
Total Current Liabilities	32.1%
Long Term Debt	72.0%
Deferred Tax Liabilities	5.2%
Other Noncurrent Liabilities	8.9%
Total Liabilities	118.1%
Equity
Common Stock	0.0%
Additional Paid In Capital	57.5%
Retained Earnings	89.8%
Accumulated Other Comprehensive Income	-11.3%
Total Stockholders Equity	136.0%
Noncontrolling Interest	1.7%
Total Liabilitiesand Equity	255.8%

Income Statement

Revenue, expense, and profitability

17 accounts · 1 year

Revenue $36.4B

Operating income $6.5B

Net income $4.8B

Account	2026	Trend
IncomeStatement
Revenues Total Revenue	100.0%
Expenses Cost of Revenue	35.0%
Expenses Research and Development	7.9%
Expenses Selling,General and Administrative	32.4%
Expenses Depreciation and Amortization	4.9%
Expenses Other Operating Expenses	1.7%
Other Income Expense Operating Income	17.8%
Other Income Expense Interest Expense	2.0%
Other Income Expense Other Income/expense	0.7%
Other Income Expense Income Before Tax	16.9%
Income Tax Income Tax Expense	3.6%
net Income Other Items Below Tax	-0.1%
net Income net Income	13.2%
net Income Comprehensive Income	13.7%
Earnings Per Share Basic Eps	0.0%
Earnings Per Share Diluted Eps	0.0%
Earnings Per Share Weighted Average Shares Diluted	3.5%

Cash Flow Statement

Operating, investing, and financing flows

22 accounts · 1 year

Operating cash flow $7.3B

Investing cash flow $-2.9B

Financing cash flow $-4.8B

Account	2026	Trend
CashFlow
Operating Activities net Income	13.3%
Operating Activities Depreciation and Amortization	8.1%
Operating Activities Stock Based Compensation	1.3%
Operating Activities Deferred Income Taxes	0.1%
Operating Activities Changes In Operating Assets and Liabilities	-3.9%
Operating Activities Other Non Cash Items	1.2%
Operating Activities net Cash From Operating Activities	20.2%
Investing Activities Capital Expenditures	-5.2%
Investing Activities Business Acquisitions	-1.1%
Investing Activities Purchases of Investments	-24.0%
Investing Activities Proceeds From Sale of Investments	22.3%
Investing Activities Other Investing Activities	-0.0%
Investing Activities net Cash From Investing Activities	-8.1%
Financing Activities Proceeds From Debt	4.8%
Financing Activities Repayment of Debt	-8.0%
Financing Activities Repurchase of Common Stock	-2.8%
Financing Activities Dividends Paid	-10.0%
Financing Activities Proceeds From Stock Issuance	2.9%
Financing Activities Other Financing Activities	0.1%
Financing Activities net Cash From Financing Activities	-13.1%
Cash Reconciliation Effect of Exchange Rate On Cash	0.2%
Cash Reconciliation net Change In Cash	-0.7%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 1 year

Ratio	2026
Profitability
Gross margin	+65.0%
Operating margin	+17.8%
Net margin	+13.2%
FCF margin	+14.9%
Growth
Revenue CAGR (3y)	+5.2%
Returns
ROE	+9.7%
ROA	+5.2%
ROIC	+6.8%
Liquidity
Current ratio	2.13x
Quick ratio	0.74x
Leverage
D/E	0.87x
Interest coverage	9.04x
Efficiency
Asset turnover	0.39x
Cash conversion cycle	+162d

Valuation

Price against fundamentals

FY2026 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched

Medtronic

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Recent price history